Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.22.1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Share-based Payment Arrangement, Option, Activity
The following is a summary of stock option activity during the three months ended March 31, 2022:
Number of
options
outstanding		 Weighted
average
exercise
price (*)		 Average
remaining
contractual life
(in years)		 Aggregate
intrinsic value
(in thousands)
Outstanding – December 31, 2021
 1,105,938  $ 2.03  8.8 $ 1,535 
Options granted
 58,000  1.91 
Options exercised
 (9,201) — 
Outstanding – March 31, 2022
 1,154,737  2.04  8.6 779 
Exercisable – March 31, 2022
 403,130  $ 0.79  7.3 $ 529 
(*) $ - Indicates exercise price less than $0.01 per share
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions For the three months ended March 31, 2022 and 2021, the assumptions used in the Black-Scholes option pricing model, which was used to estimate the grant date fair value per option, were as follows:
Three months ended March 31,
2022 2021
Weighted-average Black-Scholes option pricing model assumptions:
Volatility 107.25  % 76.90  %
Expected term (in years) 5.80 5.66
Risk-free rate 1.47  % 0.48  %
Expected dividend yield $ —  $ — 
Weighted average grant date fair value per share $ 1.55  $ 1.59 
Share-based Payment Arrangement, Expensed and Capitalized, Amount
The following is a summary of stock-based compensation expense for stock options:
Three months ended March 31,
2022 2021
General and administration $ 120,876  $ 5,546 
Research and development 25,832  3,850 
$ 146,708  $ 9,396 
Schedule of Nonvested Restricted Stock Units Activity
The following is a summary of RSA’s awards activity during the three months ended March 31, 2022:
Three months ended March 31, 2022
Numbers of Shares Weighted Average Grant Date Fair value
Non-Vested at beginning of period 30,000  $ 3.20 
Shares vested 3,750  3.20 
Non-vested 26,250  $ 3.20